Considering that RARRES3 and TNFSF10 are both downstream genes of TP53, and TNFSF10 is a validated prognostic risk factor for PAAD, we used TNFSF10 as a comparator to evaluate the prognostic value of RARRES3. This evidence concerns the gene TP53 and pancreatic adenocarcinoma.